2785.0000 35.80 (1.30%)
NSE Aug 29, 2025 15:31 PM
Volume: 70,828
 

2785.00
1.30%
Karvy
Revenues for the quarter at Rs 7880 mn were below our estimates of Rs 8195 mn. The operating margins at 21% in Q1FY20 were below our estimates of 23.2% on account of lower revenue traction and lower gross margin.
GlaxoSmithKline Pharmaceuticals Ltd. is trading above its 200 day SMA of 2701.2
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended